Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 272 of 640

Advanced search

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Avandia Lawsuits

aboutlawsuits.comOriginal source

🇺🇰Aug 13Regulatorygov.ukTier 1 · Regulatory source

Drug misuse and dependence: UK guidelines on clinical management

How clinicians should treat people with drug misuse and drug dependence problems.

UK Department of Health and Social CareOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Assenagon Asset Management S.A. Sells 2,136,807 Shares of Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Macro Group Pharmaceutical Q2 Consol Profit 51.1 Mln

TradingViewOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

The 82x ROI Claim Looks Great on a Slide Deck — But Who’s Paying for the Infrastructure at the Site?

The Clinical Trial VanguardOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

PanGen Biotech Q2 sales rise 13.5% on EPO exports, but costs push it into loss

koreabiomed.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe: Maharashtra FDA Commissioner Behind Food Safety Raids

BrutOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

PFAS: is pharmaceutical manufacturing prepared for the next compliance challenge?

Manufacturing ChemistOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

From petri dish to patient:biotech’s formidable obstacle course

SMH.com.auOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Atea’s Bemnifosbuvir/Ruzasvir Meets Phase 3 Endpoints in Hepatitis C Trial

The Clinical Trial VanguardOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Understanding MedTrust Health: Why This Company Can Legally Charge Fees From Both Pharmaceutical Enterprises and Insurance Companies

36KrOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Inspects 434 Ayurvedic Drug Makers, Issues 135 Show-Cause Notices, Cancels 10 Licences

Medical DialoguesOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-Led Maharashtra FDA Suspends Licences of 4 Domino's Outlets in Mumbai and Satara; Check

latestly.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. Report Zipalertinib Plus Chemotherapy Meets Primary Endpoint in Phase 3 Rezilient3 Trial in First-Line Egfr Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

marketscreener.comOriginal source

🌍Aug 13Researchamref.orgTier 2 · Direct publisher

Amref Learnings and Research Round Up July 2026

Amref Health AfricaOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Laura Gunter: Congress could undermine NC’s biotech boom

Salisbury PostOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Integrating Fleet Data Streams Reduces Operational Inefficiencies in Pharmaceutical Logistics

geneonline.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

What it’s like to work as a scientist in the pharmaceutical industry

American Society for Biochemistry and Molecular BiologyOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

biospace.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

'Shooting first and asking questions later' does not apply in law: Bombay HC raps Maharashtra food safety body

cnbctv18.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Zealand Pharma Announces Financial Results for the First Half of 2026

The Manila TimesOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Suspends Licenses of 11 Food Outlets in Statewide Safety Crackdown

AD HOC NEWSOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Food Safety Crackdown: FDA Suspends Licences Of 4 Domino’s Outlets

Outlook IndiaOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

What The FDA's Latest Move On Psychedelics Means For Non-Hallucinogenic Drug Sponsors

Clinical LeaderOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Domino Effect: Maharashtra FDA suspends licences of four Domino's Pizza outlets over hygiene, food-safety vi..

ET BrandEquityOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs

Analytik NEWSOriginal source

🇺🇸Aug 13Regulatoryfda.govTier 1 · Regulatory source

Intravascular Administration Set Recall: Baxter Removes Duo-Vent Solution Sets

Baxter administration sets may have air bubbles in the drip chamber and tubing, which may result in...

FDA MedWatchOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

India News

LatestLYOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) Insider Andrew Stewart Plump Sells 165,393 Shares of Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) Insider Sells $531,519.30 in Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) CEO Sells $1,523,439.00 in Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Gabriele Ricci Sells 25,088 Shares of Takeda Pharmaceutical (NYSE:TAK) Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) General Counsel Natalie Anne Marie Furney Sells 30,868 Shares of Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) Insider Nicola Deidre Petal Greenway Sells 6,774 Shares of Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Insider Selling: Takeda Pharmaceutical (NYSE:TAK) Insider Sells $124,436.70 in Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Insider Selling: Takeda Pharmaceutical (NYSE:TAK) Insider Sells 47,586 Shares

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (NYSE:TAK) Insider Sells $392,564.70 in Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Elaine Mary Shannon Sells 3,978 Shares of Takeda Pharmaceutical (NYSE:TAK) Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA permanently cancels licences of 10 Ayurvedic drug firms over violations

Mid-DayOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals (ASX:RCE) Upgrades Australian Diabetic-Foot Trial to Pivotal Phase 3

KalkineOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Is Santen (TSE:4536) Turning Flat Sales Into a Stronger Profit Story?

simplywall.stOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ?

The Motley FoolOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Bernhard completes long-delayed utilities acquisition; Swiss biotech raises $152m Series B

Alternatives WatchOriginal source

🌍Aug 13Researchindicalab.comTier 2 · Direct publisher

Workshop: HALOを用いたMASHモデルマウスの定量的病理組織解析とその有用性

Indica LabsOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus

simplywall.stOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Celltrion Secures FDA Fast Track for All Three ADC Drug Candidates

finance.biggo.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea

데일리팜Original source

🇺🇸Aug 13Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Government-Owned Inventions; Availability for Licensing

The inventions listed below are owned by an agency of the U.S. Government and are available for lice...

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

National Eye Institute; Notice of Meeting

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets

The Food and Drug Administration (FDA or the Agency) is announcing a formal evidentiary public heari...

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection; Public Comment Request: Information Collection Request Title: SAMHSA Data Security Requirements for Accessing Confidential Data (OMB No. 0930-0396)

Substance Abuse and Mental Health Services (SAMHSA), within the Department of Health and Human Servi...

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children

This final rule requires that a State Medicaid plan must provide that the Medicaid agency will not m...

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Medicare Program; Alternative Payment Model (APM) Incentive Payment Advisory for Clinicians-Request for Current Billing Information for Qualifying APM Participants

This advisory is to alert certain clinicians who are Qualifying Alternative Payment Model (APM) part...

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Center For Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source

🇺🇸Aug 13Regulatoryfederalregister.govTier 1 · Regulatory source

Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source

🌍Aug 13Industryrss.globenewswire.comTier 3 · Secondary coverage

ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

ARS PharmaceuticalsOriginal source

🇺🇸Aug 13Researchonlinejcf.comTier 2 · Direct publisher

AI-Derived Score to Predict Effort Intolerance and Adverse Outcome across the Heart Failure Spectrum

Journal of Cardiac FailureOriginal source

🇺🇸Aug 13Researchonlinejcf.comTier 2 · Direct publisher

Beta‐Blocker Discontinuation in Heart Failure with Preserved or Improved Ejection Fraction: A Systematic Review

Journal of Cardiac FailureOriginal source